02-Dec-2013 - Strategic partnerships are “the next phase” of sponsor-CRO relations, according to Parexel, and on top of saving pharma on oversight costs will reshape the industry.
02-Dec-2013 - Private equity will be looking to exit the CRO industry and could pose a threat to recent strong growth, according to financial experts at PCT
02-Dec-2013 - Trust, transparency and end-to-end participation are just some of the reasons Merck Serono says its exclusive strategic partnership with Quintiles is the “first of its kind.”
25-Nov-2013 - Smartphones are changing the role of the patient in clinical trials and can be used for industry success, Pfizer and technology provider firm Exco InTouch said at PCT 2013.
21-Nov-2013 - Economic uncertainty and a bleak fiscal outlook will lead to over-regulation and increased fines in the clinical trial industry, according to an economic expert at PCT.
21-Nov-2013 - Strategic partnerships were put on trial yesterday at PCT and with a number of alliances coming up for renewal, Pfizer, Novartis, Amgen and Baxter spoke about the issues affecting a...
19-Nov-2013 - [View the story "Ultravox wrong: Vienna 'everything' to CROs this week" on Storify]
19-Nov-2013 - Are strategic alliances a positive or a negative thing for the CRO industry as a whole? In light of PCT Europe this week, we invite you to comment.
18-Nov-2013 - Venn Life Sciences has broadened its global footprint with the acquisition of a German CRO and says it is looking for more growth opportunities.
13-Nov-2013 - US CRO PRA International has announced plans to buy privately-owned early phase trial specialist CRI Lifetree.
12-Nov-2013 - India’s CDSCO has unveiled a list of clinical trial regulations that does little to explain how they will fix a system that has seen an increasing number of companies pulling...
07-Nov-2013 - Plagued with tighter deadlines and calls for more efficiency, CROs (contract research organizations) seem to be increasingly turning to apps and cloud-based systems to develop CTMS (clinical trial management system)...
06-Nov-2013 - CRO Quintiles said that it paid $146.5M in cash for oncology and device CRO Novella Clinical.
05-Nov-2013 - After almost two years of lagging early phase clinical research work, it seems some CROs are now seeing an uptick in specialized trials that require more scientific expertise.
04-Nov-2013 - CRO Parexel’s stock fell to a four-month low and continued to hover around that level late last week following concerns about low bookings and increased competition in the first quarter...
31-Oct-2013 - Quintiles issued a mixed set of revised financial predictions for 2013, increasing its earnings per share forecast after a surge of new business wins and narrowing its service revenue.
29-Oct-2013 - inVentiv Health has opened a new UK office in order to better target European customers, whilst Novum says its North Dakota facility will strengthen its offerings.
28-Oct-2013 - Despite a strong Q3, Icon has outlined plans for further cuts at its UK clinical pharmacology unit (CPU) as it rejigs its ‘weak’ early phase services business.
21-Oct-2013 - Medical device specialist CRO Clinlogix has nearly doubled its number of employees with the acquisition of German contractor ikfe CRO GmbH.
17-Oct-2013 - CRO Clinlogix has expanded its reach in Europe with the acquisition of German CRO ikfe CRO GmbH.
17-Oct-2013 - Early stage drug developer Charles River Laboratories is pushing further into Asia with its purchase of the microbiology subcontractor BRASS Pte Ltd. Terms of the acquisition were not disclosed.
16-Oct-2013 - Yale University’s Cardiovascular Research Group (YCRG) and medical device CRO genae associates nv, have announced a collaboration and co-marketing agreement for cardiovascular devices.
16-Oct-2013 - CRO Quintiles has decided to close its Phase I unit in Hyderabad, India, because of a “challenging external business environment,” a company spokesman told us.
15-Oct-2013 - Parexel has teamed up with Japanese trial management services firm Fuijitsu Systems West in an agreement that underlines the CROs eClinical growth ambitions in Asia.
14-Oct-2013 - The Cmed Group has realigned its US operations with two new offices planned to suit the geographical needs of its clients.